- AU$35.32m
- AU$38.11m
- AU$15.22m
- 13
- 21
- 54
- 20
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 5.79 | ||
Price to Tang. Book | 5.9 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.45 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -172.52% | ||
Return on Equity | -134.23% | ||
Operating Margin | -116.4% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 7.55 | 6.78 | 13.11 | 15.01 | 15.22 | 23.9 | 28.2 | 23.43% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Micro-X Limited is an Australia-based company engaged in developing and commercializing a range of products for global health and security markets, based on cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight, and power requirements, enabling mobility and ease of use in existing x-ray markets and a range of security and defense applications. Its product portfolio spans four, high margin, product applications in health and security. The Company's segments include Micro-X Limited and Micro-X Inc. Its products include Mobile X-Ray Machines, Argus X-Ray Camera, Miniature Baggage Scanner, and Head CT. The Company's commercial mobile digital radiology products are sold for diagnostic imaging in global healthcare, military, and veterinary applications, and the Argus X-ray Camera for security and defense and is also available commercially.
Directors
- David Knox NEC (59)
- Peter Rowland CEO
- Kingsley Hall CFO
- Charlie Hicks GMG
- Alexander Gosling DRC
- Yasmin King NED
- Jim McDowell NED
- Patrick O'Brien NED
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 16th, 2011
- Public Since
- December 22nd, 2015
- No. of Shareholders
- 3,883
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 588,620,974.06

- Address
- A14 6 MAB Eastern Promenade, ADELAIDE, 5042
- Web
- https://micro-x.com/
- Phone
- +61 870993966
- Auditors
- BDO Audit Pty Ltd
Upcoming Events for MX1
Similar to MX1
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 22:02 UTC, shares in Micro-X are trading at AU$0.06. This share price information is delayed by 15 minutes.
Shares in Micro-X last closed at AU$0.06 and the price had moved by -39.44% over the past 365 days. In terms of relative price strength the Micro-X share price has underperformed the ASX All Ordinaries Index by -40.34% over the past year.
The overall consensus recommendation for Micro-X is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMicro-X does not currently pay a dividend.
Micro-X does not currently pay a dividend.
Micro-X does not currently pay a dividend.
To buy shares in Micro-X you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.06, shares in Micro-X had a market capitalisation of AU$35.32m.
Here are the trading details for Micro-X:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: MX1
Based on an overall assessment of its quality, value and momentum Micro-X is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Micro-X is AU$0.17. That is 183.33% above the last closing price of AU$0.06.
Analysts covering Micro-X currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.01 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Micro-X. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -13.52%.
As of the last closing price of AU$0.06, shares in Micro-X were trading -14.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Micro-X PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Micro-X's management team is headed by:
- David Knox - NEC
- Peter Rowland - CEO
- Kingsley Hall - CFO
- Charlie Hicks - GMG
- Alexander Gosling - DRC
- Yasmin King - NED
- Jim McDowell - NED
- Patrick O'Brien - NED